AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2015
Feb 18, 2015
29821_dirs_2015-02-18_fdfba468-6f8b-407a-802f-174de6afddf3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2015-02-16
Reporting Person: Phalen Michael P. (EVP & President, MedSurg)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-16 | Common Stock | M | 4723.0000 | $0.0000 | Acquired | 113789.0000 | Direct |
| 2015-02-16 | Common Stock | F | 1535.0000 | $14.9800 | Disposed | 112254.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-16 | Deferred Stock Units | $ | M | 4723.0000 | Disposed | Common Stock (4723.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2433.0000 | Indirect |
Footnotes
F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
F3: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F4: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 16, 2011, the first anniversary of the date of grant.
F5: Reflects multiple DSU awards with independent vesting schedules.